iRhythm Technologies (IRTC) TAM Expanded By iWatch Trial - Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst David Lewis reiterated an Overweight rating and $101.00 price target on iRhythm Technologies (NASDAQ: IRTC) after data ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
